Back in the sea of clouds, Qin Lang had a meal with Xiaorui, as well as Uncle Ye and Aunt Yun.

At the dinner table, Aunt Yun, who came over, also saw a secret between Qin Lang and her daughter Ye Xiaorui, but she didn't break it, she was just happy.

After all, her daughter's first hand over to Qin Lang, as a mother, she would also be happy for her daughter's choice.

When Qin Lang returned to Lanrun Company, he learned that Yasta Medicine had not moved for the time being, but it was obvious that Yasda Medicine could not easily give up retaliation, so Qin Lang continued to ask Tang Qian to collect some evidence to prove his patent autonomy to the international court, and at the same time prepare to fight back against the conspiracy of Yasda, the world pharmaceutical giant, against Lanrun Pharmaceutical.

In the process of investigation, Lanrun Group found that Yashida did use some small means before, and somehow stole some pharmaceutical trade secrets about Lanrun, and used the relationship in advance to apply for patents that are exactly the same as Lanrun technology in some countries.

Internationally, Yasta Pharmaceutical has an incomparably strong production capacity, and its main projects are anti-cancer series, detoxification and beauty, liver and kidney protection and other related pharmaceutical products.

And this time, after stealing some of the trade secrets of Lanrun Pharmaceutical, Yasda is making some improvements in drug production, and actually wants to replicate the successful case of Lanrun Pharmaceutical.

It's a pity that these doomed methods of the other party can't be put on the table, because Lanrun grabbed some of the other party's handles during the investigation, for example, the guy who leaked pharmaceutical trade secrets was caught.

This is a researcher in the medical laboratory, named Kadi, who is one of the batches that Qin Lang brought back to China from country M, and this researcher is actually related to IESDA, because he has a younger brother who works in IESDA's medical laboratory.

After catching this researcher, Lanrun Group found a lot of evidence of Kadi's leakage of trade secrets, and with these materials and factual evidence, Lanrun can fight a counterattack and turn the plaintiff of Yashida into a defendant.

However, Lanrun Group was not in a hurry, but asked Cardi to continue to keep in touch with Yasda, and continued to pretend that he had not been discovered by Lanrun in the dark song.

Of course, it was not easy to control Cardi to do this, and even Qin Lang had to use some cultivator methods to make Cardi completely succumb under mental pressure.

After IESDA, an international pharmaceutical leader, who had been unaware, stole the secrets of Lanrun Pharmaceutical at the moment, it was also overjoyed and began to organize pharmaceutical manufacturers under the group to produce new drugs similar to the patented drugs of Lanrun Group, and produced quite a lot of finished drugs.

After all, IELTA is the world's leading pharmaceutical company, and its production capacity exceeds that of Lanrun Group, one of the world's top 500 companies, and its production capacity is not known how many times.

It's a pity that the idiots at IELTA don't know that the more they produce now, the more they will lose in the future.

After all, these large quantities of new drug products produced secretly are serious infringements, and the patent protection of drugs under the International Pharmaceutical Patent Law is also quite strict.

This time, under Qin Lang's instructions, the entire Lanrun Group turned into a secret poisonous snake, preparing to give Yashida a fatal blow.

After all, passively waiting to defuse the attack of Yasta Pharmaceutical Group is no longer in line with the requirements of Qin Lang and Lanrun, and giving the other party a head-on blow on the basis of defusing the opponent's offensive is what Qin Lang and Lanrun Group want to achieve.

And far away in North America, IESDA headquarters.

Royce is having a father-son conversation with his father, Barmas, the president of Yasta Pharmaceutical Group.

"This time, son, you did a good job, with some information you provided...... Our people contacted Cass inside Huaxia Lanrun Laboratory through Mion, and asked them to meet the two brothers, so that Cass would be completely used by us. Barmas said with a smile.

It turned out that when the people on Royce's side were in the Middle East, they saw Cass next to Qin Lang, and felt that this Cass looked very similar to Miang from the Yasda Pharmaceutical Laboratory, and only after secret contact did they know that the two were actually twins, which also opened the foundation for later buying this traitor.

Knowing that his younger brother was serving IESDA, Cass, the anti-bone boy, betrayed the Lanrun Life Science Laboratory without hesitation, stole some important research materials from the laboratory, and passed them on to Yasda.

Cass didn't know the consequences of his doing so, and he completely sentenced his future and future to death, and neither Lan Run's side nor Yasda would accept him in the future.

This fool is completely the target of stupid use, including his brother Mion, who may be pushed out by Yasda Pharmaceutical Group in the future.

After all, stealing other people's pharmaceutical patents is a taboo in the international pharmaceutical industry, and IES has a big business and pays great attention to the protection of its wings, which is a very reputational thing.

"Father, if you go down with this summons, I believe that Lanrun Medicine in Huaxia has become a mess of porridge now, and it is a good chess game. ”

And Royce was also very impressed by his father's methods at this time, if he couldn't think of such a poisonous plan of a thief shouting and touching a thief.

It would be a great thing if the entire Blue Run Pharmaceutical Group could be directly brought down through this summons, then the entire IELTA could openly use the patented technologies of Blue Run Pharmaceutical, and the outside world would not say anything more.

After all, Lanrun Pharmaceutical has collapsed by then, and even if the outside world wants to complain about itself, it will not be able to find a sufferer.

"Hehe, the mall is like a battlefield, and you must rack your brains to be ruthless against the enemy...... At this point, son, you must not learn more, this is also the accumulation of social experience. ”

Barnas is also proud of his clever move, this time the move is simply miraculous, if successful, the benefits to IESDA are too great, equivalent to the entire group in advance of the development of ten years of overdrive.

After all, the patented technology of the three drugs of Lanrun Pharmaceutical is very advanced in the world's pharmaceutical industry, and this risk must be taken a little...... There are also people who dare to take risks.

"Yes, my father is very clever. ”

Royce was convinced at the moment, and at the same time secretly had a hint of pride: "The Oriental boy who offended me, now it's up to you how you end!"

What the two don't know is that everything they are discussing now is actually under the control of Lanrun Group, Qin Lang let people control Cass, and mastered a large amount of effective evidence of Yasda's theft of patented technology, and he is also ready to let Yasda, an international pharmaceutical giant, bleed heavily.

Maybe it's a little lighter to say that the hemorrhage is a little lighter, this time I'm afraid that IESDA's reputation in the entire international pharmaceutical industry will stink, and it is uncertain whether it will be able to keep the position of the boss of Longda in the future.

The battle of wits between the two sides is in full swing, with one international summons after another, and the lawsuit has been fought back and forth many times, but there has been no victory.

On the surface, it seems that the current Lanrun Pharmaceutical has fallen into the trouble of lawsuits, and the international patent application for the new drug "Anti-Cancer No. 3" has been delayed, and the development speed of the group has been seriously hindered and slowed down a lot in recent times.

However, the high-level executives of the entire Lanrun Group who know the truth are secretly laughing in their hearts, this is Qin Lang controlling everyone to hold back, once the truth of the facts is exposed to the outside world in the future, I am afraid that it is time to reverse the plot.

Don't be in a hurry, don't be in a hurry, really not in a hurry, now the heat and timing are not enough.

Either you don't fight, or if you want to fight, you will definitely beat the enemy to the pain, cripple, or kill you, and this will have an effect...... Isn't it?

Therefore, for almost the next two or three months, Lanrun and Yalta went back and forth on this lawsuit, and Yalta has been acting as the complainant, but the evidence given is not relatively vague, and every time it cannot effectively rectify Lanrun Pharmaceutical.

And Lanrun Pharmaceutical has been passive every time, but there is no favorable evidence to get itself out of the quagmire of this lawsuit, and every time it seems that it is just about to get out of the quagmire, and it is pulled back by a summons from Yasda.

This is a long tug-of-war, IESDA, as the world's No. 1 entrepreneur, can naturally afford to consume it, and Lanrun, an emerging top 500 pharmaceutical company, seems to have spent most of its energy and resources on fighting lawsuits, which seems to be a little weak.

This can be seen from the sales performance of the pharmaceutical sector of Lanrun Group in recent months.

Before the Lanrun pharmaceutical sector fell into the quagmire of patent technology complaint lawsuits, the monthly sales of pharmaceutical products had reached 500 million US dollars.

One month after falling into the quagmire of patent technology complaints, monthly sales were about 600 million US dollars, an increase of 100 million.

By the second month, monthly sales were about $650 million, an increase of only $50 million over the first month.

In the third month, monthly sales were about $680 million, an increase of only $30 million over the second month.

This phenomenon of slower and slower monthly sales growth does not mean that Lanrun Pharmaceutical's products have reached a state of market saturation, but are caused by some adverse effects.

After all, the new drug products have only been out for a short time, and they have not yet fully occupied the domestic sales market, and the current market share has only reached 33.5 percent!

The main source of the adverse effects is the quagmire of Yasda's lawsuit against Lanrun Pharmaceutical, which has shaken the credibility of Lanrun Group and caused some resistance to Lanrun products.

It seems that now at this juncture, Lanrun Group also needs to start to make some necessary counterattacks, otherwise, if it is suppressed for too long, not only the entire international pharmaceutical market, but also the domestic pharmaceutical market in China will gradually have some bad ideas about Lanrun Pharmaceutical, which is stubborn and difficult to change, and will even affect the future development of Lanrun Pharmaceutical.

It's time to make a counterattack, when Qin Lang issued this notice, Tang Qian of Lanrun Group quickly made an execution, and the counterattack of the entire Lanrun Group began.

A new patent complaint report was passed on to the international court, and this time the complainant became Lanrun Pharmaceutical Group Co., Ltd., complaining that Yasda, the world's leading pharmaceutical company, had seriously infringed on Lanrun Pharmaceutical, and the evidence was clear!